Plasmid-mediated ciprofloxacin resistance imparts a selective advantage on Escherichia coli ST131.

Published: Nov 15, 2021
Abstract
Escherichia coli ST131 is a recently emerged antibiotic resistant clone responsible for high rates of urinary tract and bloodstream infections. Despite its global dominance, the precise mechanisms that have driven the rapid dissemination of ST131 remain unknown. Here, we show that the plasmid-associated resistance gene encoding the AAC(6')-Ib-cr enzyme that inactivates the fluoroquinolone antibiotic ciprofloxacin is present in >70% of strains...
Paper Details
Title
Plasmid-mediated ciprofloxacin resistance imparts a selective advantage on Escherichia coli ST131.
Published Date
Nov 15, 2021
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.